Search results for " CELL CARCINOMA"

showing 10 items of 477 documents

Efecto de la radiación ionizante persistente a bajas dosis en la angiogénesis del carcinoma renal de células claras : estudio morfométrico comparativ…

2013

La angiogénesis en el carcinoma de células renales claras (ccRCC) es un proceso influenciado por sustancias producidas en su mayoría por el tumor en respuesta a una reestructuración vascular necesaria en su etapa de crecimiento y metástasis. La exposición persistente a bajas dosis de radiación ionizante (CPLDIR) ha sido asociada a modificaciones nucleares que estimulan la proliferación celular neoplásica. Sus efectos en el proceso de neovascularización de los ccRCC han sido poco estudiados. Métodos: Estudiamos a través de un estudio morfométrico semiautomático e inmunohistoquímico, la densidad microvascular (MVD) y la expresión de factores angiogénicos en 124 pacientes con ccRCC de regiones…

angiogenesisclear cell renal cell carcinoma (ccRCC)microvascular density (MVD)UNESCO::CIENCIAS MÉDICASimmunohistochemistryangiogenic factorsradiation exposure to persistent low-dose (CPLDIR):CIENCIAS MÉDICAS [UNESCO]morphometry
researchProduct

Primary Analysis of Phase 2 Results for Cemiplimab in Patients (pts) with Locally Advanced Basal Cell Carcinoma (laBCC) who Progress on or are Intole…

2021

Abstract not available.

business.industryLocally advancedmedicineCancer researchBasal cell carcinomaIn patientmedicine.diseasebusinessHedgehogSKIN The Journal of Cutaneous Medicine
researchProduct

Mucocutaneous Leishmaniasis Mimicking Squamous Cell Carcinoma

2019

Leishmaniasis is a parasitic infectious disease caused by protozoan species belonging to the [...]

business.industryParasitic infectious diseaseparasitic diseasesMedicineLeishmaniasisBasal cellMucocutaneous leishmaniasisbusinessmedicine.diseaseVirologyMucocutaneous Leishmaniasis Squamous Cell CarcinomaThe XV National and III International Congress of the Italian Society of Oral Pathology and Medicine
researchProduct

Heat Shock Proteins in Renal Cell Carcinomas

2005

Renal cell carcinoma (RCC) represents one of the most common cancer types in the Western World. One third of the RCC patients had metastasis at presentation with a poor 5-year survival. Nephrectomy is the most important treatment modality of this disease, since most of the RCCs are resistant to cytotoxic chemotherapy and radiation therapy. Recent immunotherapeutic approaches have been shown to improve the survival rate of RCC patients. Thus, RCC appears to have an immunogenic basis, and therefore represents an attractive target for immunotherapies. So far, only a few RCC-associated antigens have been characterized. However, with the implementation of ome-based technologies, an increasing nu…

business.industrymedicine.medical_treatmentCancerContext (language use)Immunotherapyurologic and male genital diseasesmedicine.diseasefemale genital diseases and pregnancy complicationsMetastasisAntigenRenal cell carcinomaHeat shock proteinImmunologymedicineCytotoxic T cellbusiness
researchProduct

Immunomorphological Patterns of Chaperone System Components in Rare Thyroid Tumors with Promise as Biomarkers for Differential Diagnosis and Providin…

2023

Hurthle cell (HC), anaplastic (AC), and medullary (MC) carcinomas are low frequency thyroid tumors that pose several challenges for physicians and pathologists due to the scarcity of cases, information, and histopathological images, especially in the many areas around the world in which sophisticated molecular and genetic diagnostic facilities are unavailable. It is, therefore, cogent to provide tools for microscopists to achieve accurate diagnosis, such as histopathological images with reliable biomarkers, which can help them to reach a differential diagnosis. We are investigating whether components of the chaperone system (CS), such as the molecular chaperones, can be considered dependabl…

chaperone system.Cancer ResearchOncologySettore BIO/16 - Anatomia Umanathyroid cancermedullary carcinomathyroid cancer; Hurthle cell carcinoma; medullary carcinoma; anaplastic carcinoma; Hsp27; Hsp60; Hsp90; chaperone systemHsp90Hurthle cell carcinomaanaplastic carcinomaHsp27Hsp60Cancers
researchProduct

Multispectral fluorescence detection of pigmented cutaneous tumours

2020

We investigated pigmented skin tumour lesions in vivo and ex vivo, including benign and dysplastic nevi, as well as malignant lesions, such as pigmented basal cell carcinoma (BCC) and malignant melanoma (MM) lesions, to obtain a complex view about the feasibility of different excitation sources solely and/or in combination to induce fluorescence signal useful for diagnosis of various low-fluorescent cutaneous neoplasia. A specialized multispectral analysis of the data obtained was applied by using excitation in broad spectral range, covering ultraviolet, visible and near-infrared spectral range, that contribute considerably to: (1) fundamental determination of tumour tissues’ spectral prope…

chemistry.chemical_classificationintegumentary systembiologyChemistryMelanomamedicine.diseaseFluorescenceMolecular biologyMelaninIn vivoKeratinmedicinebiology.proteinBasal cell carcinomaSkin cancerElastinBiophotonics—Riga 2020
researchProduct

Primary Epithelial Ovarian Neoplasms: New Concepts Concerning Origin, Pathogenesis and Classification Based on Morphology, Immunomarkers, Molecular F…

2011

The World Health Organization (WHO) classification of ovarian tumors, which first appeared in 1983 and since then has undergone a number of revisions, is based on morphologic features as well as on the concept that each category of ovarian tumors develops from a specific ovarian cell. According to this histogenetic classification, all the epithelial ovarian neoplasms are derived from the ovarian surface epithelium and/or from ovarian inclusion cysts, which are lined by the above epithelial cells. In recent years, a new approach to morphologic data, increasing presumptive evidence that the cell of origin of most, if not all, ovarian epithelial tumors may be extraovarian, especially from fall…

endocrine systemPathologymedicine.medical_specialtyendocrine system diseasesSerous carcinomaMedicine (all)Cell of originDiseaseBiologymedicine.diseasefemale genital diseases and pregnancy complicationsTherapeutic approachOvarian tumormedicine.anatomical_structureClear cell carcinomamedicineOvarian cancerFallopian tube
researchProduct

VHL gēna mutācijas gaišo šūnu nieru karcinomas gadījumā

2019

Nieru šūnu karcinoma ir sestais biežāk diagnosticētais audzējs no visām onkoloģiskajām diagnozēm pasaulē. Gaišo šūnu nieru karcinoma ir 65-70% no visiem saslimšanas gadījumiem ar nieru audzējiem. Izmaiņas von Hippel-Lindau (VHL) gēnā, kurš ir visbiežāk mutētais gēns gaišo šūnu nieru karcinomas gadījumā, tiek salīdzinātas starp in vitro audzētām cilvēku nieru proksimālo kanāliņu epitēlija šūnām un gaišo šūnu nieru karcinomas šūnu līnijām un primārajām šunām, kuras iegūtas no gaišo šūnu nieru karcinomas pacientu audiem un blakus esošiem veselajiem audiem. Darba rezultātā tika konstatēts viena nukleotīda polimorfisms pacientu gaišo šūnu nieru karcinomas audos un veselajos audos no VHL gēna izo…

gaišo šūnu nieru karcinomaFarmācijaclear cell renal cell carcinomavon Hippel-Lindau
researchProduct

New perspectives in medical approach to therapy of head and neck squamous cell carcinoma

2009

Head and neck cancer is the eighth most common cause of cancer death worldwide. Its incidence varies widely among different regions. In North America and the European Union, head and neck cancer accounts for 3% to 4% of all cancer diagnoses. Conversely, in Southeast Asia and Africa, head and neck cancer accounts for approximately 8% to 10% of all cancers1. Although the incidence of head and neck cancers has decreased slightly from 1975 to 2002 in the United States5, approximately 46 000 new cases are still expected in 2007 alone. Even if surgery and radiotherapy have remained the core therapy in squamous cell carcinoma of the head and neck (HNSCC). Radiotherapy following surgery was the sta…

head neck squamous cell carcinoma therapySettore MED/28 - Malattie Odontostomatologiche
researchProduct

Hyperspectral imaging system in the delineation of Ill-defined basal cell carcinomas : a pilot study

2019

Background Basal cell carcinoma (BCC) is the most common skin cancer in the Caucasian population. Eighty per cent of BCCs are located on the head and neck area. Clinically ill‐defined BCCs often represent histologically aggressive subtypes, and they can have subtle subclinical extensions leading to recurrence and the need for re‐excisions. Objectives The aim of this pilot study was to test the feasibility of a hyperspectral imaging system (HIS) in vivo in delineating the preoperatively lateral margins of ill‐defined BCCs on the head and neck area. Methods Ill‐defined BCCs were assessed clinically with a dermatoscope, photographed and imaged with HIS. This was followed by surgical procedures…

ihosyöpäkuvantaminenskin cancerbasal cell carcinomahyperspectral imagingspektrikuvausMatematiikka - MathematicsFysiikka - Physical sciencesSyöpätaudit - Cancersimagingspectral imagingmarginstyvisolusyöpäBCC
researchProduct